158 related articles for article (PubMed ID: 29862121)
1.
Thao NP; Binh PT; Luyen NT; Hung TM; Dang NH; Dat NT
J Anal Methods Chem; 2018; 2018():2794904. PubMed ID: 29862121
[TBL] [Abstract][Full Text] [Related]
2. Wedtrilosides A and B, two new diterpenoid glycosides from the leaves of Wedelia trilobata (L.) Hitchc. with α-amylase and α-glucosidase inhibitory activities.
Luyen NT; Binh PT; Tham PT; Hung TM; Dang NH; Dat NT; Thao NP
Bioorg Chem; 2019 Apr; 85():319-324. PubMed ID: 30654223
[TBL] [Abstract][Full Text] [Related]
3. Identification of Antidiabetic Compounds from Polyphenolic-rich Fractions of
Odeyemi SW; Afolayan AJ
Pharmacognosy Res; 2018; 10(1):72-80. PubMed ID: 29568191
[TBL] [Abstract][Full Text] [Related]
4. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves.
Poongunran J; Perera HK; Jayasinghe L; Fernando IT; Sivakanesan R; Araya H; Fujimoto Y
Pharm Biol; 2017 Dec; 55(1):206-211. PubMed ID: 27927056
[TBL] [Abstract][Full Text] [Related]
5. Structurally Diverse Sesquiterpenoids with NO Production and α-Glucosidase Inhibitory Activities from the Fruits of Schisandra chinensis.
Sun P; Pan YB; Ma RF; Zhao XC; Wang YY; Miao L; Zhang H
Chem Biodivers; 2023 Oct; 20(10):e202301203. PubMed ID: 37679302
[TBL] [Abstract][Full Text] [Related]
6. Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr.
Cai C; Zhang Y; Yang D; Hao X; Li S
Nat Prod Res; 2017 Nov; 31(21):2531-2536. PubMed ID: 28475376
[TBL] [Abstract][Full Text] [Related]
7. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
Trinh BTD; Staerk D; Jäger AK
J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of
Etsassala NGER; Badmus JA; Marnewick JL; Iwuoha EI; Nchu F; Hussein AA
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33228164
[TBL] [Abstract][Full Text] [Related]
9.
Chipiti T; Ibrahim MA; Singh M; Islam MS
Pharmacogn Mag; 2017 Jul; 13(Suppl 2):S329-S333. PubMed ID: 28808401
[TBL] [Abstract][Full Text] [Related]
10. Alpha-amylase Inhibition and Antioxidant Activity of Marine Green Algae and its Possible Role in Diabetes Management.
Unnikrishnan PS; Suthindhiran K; Jayasri MA
Pharmacogn Mag; 2015 Oct; 11(Suppl 4):S511-5. PubMed ID: 27013787
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory, free radical scavenging and alpha-glucosidase inhibitory activities of Hamelia patens and its chemical constituents.
Jiménez-Suárez V; Nieto-Camacho A; Jiménez-Estrada M; Alvarado Sánchez B
Pharm Biol; 2016 Sep; 54(9):1822-30. PubMed ID: 26731099
[TBL] [Abstract][Full Text] [Related]
13. Standardized Emblica officinalis fruit extract inhibited the activities of α-amylase, α-glucosidase, and dipeptidyl peptidase-4 and displayed antioxidant potential.
Majeed M; Majeed S; Mundkur L; Nagabhushanam K; Arumugam S; Beede K; Ali F
J Sci Food Agric; 2020 Jan; 100(2):509-516. PubMed ID: 31487036
[TBL] [Abstract][Full Text] [Related]
14. Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study.
Oboh G; Agunloye OM; Adefegha SA; Akinyemi AJ; Ademiluyi AO
J Basic Clin Physiol Pharmacol; 2015 Mar; 26(2):165-70. PubMed ID: 24825096
[TBL] [Abstract][Full Text] [Related]
15. Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.
Nazir N; Zahoor M; Nisar M; Khan I; Karim N; Abdel-Halim H; Ali A
BMC Complement Altern Med; 2018 Dec; 18(1):332. PubMed ID: 30545352
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus.
Franco RR; da Silva Carvalho D; de Moura FBR; Justino AB; Silva HCG; Peixoto LG; Espindola FS
J Ethnopharmacol; 2018 Apr; 215():140-146. PubMed ID: 29274842
[TBL] [Abstract][Full Text] [Related]
17. A new sulphated flavone and other phytoconstituents from the leaves of Tetracera indica Merr. and their alpha-glucosidase inhibitory activity.
Alhassan AM; Ahmed QU; Latip J; Shah SAA
Nat Prod Res; 2019 Jan; 33(1):1-8. PubMed ID: 29417849
[TBL] [Abstract][Full Text] [Related]
18. Lignan and phenolic glycosides from
Tang YY; Chen J; Zhou HJ; Ji W; Shao JH; Zhang FM; Zhao CC
Nat Prod Res; 2023 Dec; ():1-7. PubMed ID: 38038051
[TBL] [Abstract][Full Text] [Related]
19. Rare diphenylheptanoid-phenylheptanoid hybrids with α-glucosidase inhibitory effects from the pollen of
Wang C; Li YP; Gong X; Gan LS; Zhang H
Nat Prod Res; 2023 Aug; ():1-11. PubMed ID: 37599620
[TBL] [Abstract][Full Text] [Related]
20. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
